Denali Therapeutics Inc. - COM (DNLI)

Historical Portfolio Holders from Q4 2017 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
120M
Holdings value Q2 2024
$2.78B
Value change Q2 2024
+$111M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
199
Number of buys Q2 2024
110
Number of sells Q2 2024
-92
Average buys Q2 2024 %
+0.001%
Average sells Q2 2024 %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 52.1K $1.52M -$39.5K $29.13 4
2024 Q2 120M $2.78B +$111M $23.22 201
2024 Q1 117M $2.4B +$121M $20.52 204
2023 Q4 111M $2.38B +$65.6M $21.46 205
2023 Q3 108M $2.22B -$6.42M $20.63 192
2023 Q2 107M $3.17B +$6.35M $29.51 196
2023 Q1 108M $2.49B +$45.6M $23.04 196
2022 Q4 106M $2.94B +$354M $27.81 192
2022 Q3 92.3M $2.83B -$29.2M $30.69 190
2022 Q2 92.6M $2.72B +$181M $29.43 175
2022 Q1 86.6M $2.79B +$39M $32.17 175
2021 Q4 85.2M $3.8B +$17.1M $44.60 203
2021 Q3 82.1M $4.14B +$170M $50.45 205
2021 Q2 77.8M $6.1B +$34M $78.44 206
2021 Q1 77.7M $4.44B +$78.7M $57.10 212
2020 Q4 66.4M $5.56B +$203M $83.76 200
2020 Q3 82.6M $2.96B +$14.4M $35.83 168
2020 Q2 82.6M $2B +$63.4M $24.18 140
2020 Q1 80.3M $1.41B +$150M $17.51 125
2019 Q4 70.7M $1.23B -$9.53M $17.42 107
2019 Q3 71.3M $1.09B -$4.57M $15.32 111
2019 Q2 63.4M $1.32B +$52.4M $20.76 112
2019 Q1 61M $1.42B +$43.6M $23.22 112
2018 Q4 68.1M $1.41B -$256K $20.66 88
2018 Q3 58.1M $1.26B +$109M $21.74 76
2018 Q2 53.3M $813M +$13.6M $15.25 66
2018 Q1 60.8M $1.2B +$60.2M $19.69 56
2017 Q4 58.1M $909M +$908M $15.64 45